These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16981185)

  • 21. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
    Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
    Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical significance of new therapies for the management of periodontal disease.
    Van Dyke TE
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):191-6. PubMed ID: 16248275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
    Farrar JT; Dworkin RH; Max MB
    J Pain Symptom Manage; 2006 Apr; 31(4):369-77. PubMed ID: 16632085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for testing a prespecified subgroup in clinical trials.
    Song Y; Chi GY
    Stat Med; 2007 Aug; 26(19):3535-49. PubMed ID: 17266164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On responder analyses when a continuous variable is dichotomized and measurement error is present.
    Kunz M
    Biom J; 2011 Feb; 53(1):137-55. PubMed ID: 21259314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual acuity as an outcome measure in clinical trials of retinal diseases.
    Beck RW; Maguire MG; Bressler NM; Glassman AR; Lindblad AS; Ferris FL
    Ophthalmology; 2007 Oct; 114(10):1804-9. PubMed ID: 17908590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a mis-specification of the response rate under standard treatment in sequential clinical trials.
    Sébille V; Bellissant E
    Fundam Clin Pharmacol; 2005 Oct; 19(5):569-78. PubMed ID: 16176336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size determination for logistic regression revisited.
    Demidenko E
    Stat Med; 2007 Aug; 26(18):3385-97. PubMed ID: 17149799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment on homogeneity tests for kappa statistics under equal prevalence across studies in reliability.
    Nam JM
    Stat Med; 2006 May; 25(9):1521-31. PubMed ID: 16220477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size and statistical power in the small-animal analgesia literature.
    Hofmeister EH; King J; Read MR; Budsberg SC
    J Small Anim Pract; 2007 Feb; 48(2):76-9. PubMed ID: 17286659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement in clinical trials: a neglected issue for statisticians?
    Senn S; Julious S
    Stat Med; 2009 Nov; 28(26):3189-209. PubMed ID: 19455540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power considerations when a continuous outcome variable is dichotomized.
    Deyi BA; Kosinski AS; Snapinn SM
    J Biopharm Stat; 1998 May; 8(2):337-52. PubMed ID: 9598427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.